FULLERTON, Calif., Aug. 14 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. announced today that, as required by its December, 2006, convertible notes offering, it filed a registration statement with the Securities and Exchange Commission for the resale by selling securityholders of $600 million aggregate principal amount of its 2.50% Convertible Senior Notes due 2036 and the common stock issuable under certain circumstances upon conversion of the Notes. The registration statement became effective immediately upon filing. Beckman Coulter will not receive any proceeds from the resale of any of the securities by the selling securityholders.
(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO )
The Notes were issued in December, 2006, in a 144A private placement transaction and are subject to the terms of a registration rights agreement filed as an exhibit to the registration statement. The registration statement, while effective, permits selling securityholders to publicly resell the securities subject to certain limitations and the satisfaction of the prospectus delivery requirements of the Securities Act of 1933, as amended.
About Beckman Coulter
Beckman Coulter, Inc. based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world supplying critical information for improving patient health and reducing the cost of care. Recurring revenues consisting of supplies, test kits, service and operating-type lease payments represent more than 75 percent of the company’s 2006 annual sales of $2.53 billion. For more information, visit www.beckmancoulter.com.
This press release does not constitute an offer to sell or the solicitation of an offer to buy securities nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Any offers of the securities will be made only by means of a prospectus.
Contacts: Mary Luthy, Beckman Coulter, Inc. Corporate Communications Phone: (714) 993-8770 E-mail: mluthy@beckman.com Robert Raynor, PhD, Beckman Coulter, Inc. Investor Relations Phone: (714) 773-8412 E-mail: rraynor@beckman.com
Photo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGOBeckman Coulter, Inc.
CONTACT: Mary Luthy, Beckman Coulter, Inc. Corporate Communications, +1-714-993-8770, mluthy@beckman.com; or Robert Raynor, PhD, Beckman Coulter,Inc. Investor Relations, +1-714-773-8412, rraynor@beckman.com
Web site: http://www.beckmancoulter.com/
